Exact Mass: 404.13618360000004
Exact Mass Matches: 404.13618360000004
Found 51 metabolites which its exact mass value is equals to given mass value 404.13618360000004
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Ala Cys Asp Pro
Ala Cys Pro Asp
Ala Asp Cys Pro
Ala Asp Pro Cys
Ala Pro Cys Asp
Ala Pro Asp Cys
Cys Ala Asp Pro
Cys Ala Pro Asp
Cys Asp Ala Pro
Cys Asp Pro Ala
Cys Glu Gly Pro
Cys Glu Pro Gly
Cys Gly Glu Pro
Cys Gly Pro Glu
Cys Pro Ala Asp
Cys Pro Asp Ala
Cys Pro Glu Gly
Cys Pro Gly Glu
Asp Ala Cys Pro
Asp Ala Pro Cys
Asp Cys Ala Pro
Asp Cys Pro Ala
Asp Pro Ala Cys
Asp Pro Cys Ala
Glu Cys Gly Pro
Glu Cys Pro Gly
Glu Gly Cys Pro
Glu Gly Pro Cys
Glu Pro Cys Gly
Glu Pro Gly Cys
Gly Cys Glu Pro
Gly Cys Pro Glu
Gly Glu Cys Pro
Gly Glu Pro Cys
Gly Pro Cys Glu
Gly Pro Glu Cys
Pro Ala Cys Asp
Pro Ala Asp Cys
Pro Cys Ala Asp
Pro Cys Asp Ala
Pro Cys Glu Gly
Pro Cys Gly Glu
Pro Asp Ala Cys
Pro Asp Cys Ala
Pro Glu Cys Gly
Pro Glu Gly Cys
Pro Gly Cys Glu
Pro Gly Glu Cys
Ruxolitinib phosphate
C17H21N6O4P (404.13618360000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Deuruxolitinib phosphate
C17H21N6O4P (404.13618360000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
1-pentyl-3-(3-O-sulfo-beta-D-galactosyl)-sn-glycerol
C14H28O11S (404.13522580000006)